Aug 28, 2018 Fuzionaire Diagnostics Announces Disease-Agnostic Platform to Radiolabel Any Molecule for ... Fuzionaire Diagnostics Announces Disease-Agnostic Platform to Radiolabel Any Molecule for …... are leveraging Fuzionaire Dx's radiolabeling platform to study and treat traditionally challenging diseases in areas such as neurology and oncology. ... read morePublished on 2018-08-28